In this issue:
- Low-dose aspirin for PI3K-altered localised CRC
- Encorafenib, cetuximab, and mFOLFOX6 in BRAF-mutated CRC
- The definition of cure in colon cancer
- Neoadjuvant + adjuvant chemotherapy in locally advanced rectal cancer
- Covered vs uncovered endoluminal stenting in obstructing CRC
- Dual ICI + neoadjuvant chemoradiotherapy in rectal cancer
- Older age threshold and oxaliplatin benefit in CRC
- Five-year CT and CEA follow-up and survival outcomes in CRC
- Frequency of CRC recurrence detection in clinic
- ctDNA-guided therapy in locally advanced colon cancer
Please login below to download this issue (PDF)